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Abstract 
Perfusion imaging is a technique that allows the detection of regional and global 
alterations in an organ blood flow, and can help to predict the onset of many diseases 
where the organ hemodynamics is modified. The ability of image contrast manipulation 
through exogenous contrast agents makes MRI a widely used technique for the 
assessment of liver perfusion in a non-invasive way. However, accurate liver perfusion 
assessment remains controversial regarding the mathematical model-based approaches 
than can be used to quantify perfusion. In general, commercially available software 
packages determine liver perfusion based on the classic and widely used Tofts model. 
This is a compartmental model that assumes contrast agent exchange between two 
compartments – blood plasma and tissue – and that there is a single input through which 
the contrast reaches the organ, and one output. The Tofts model has to suffer 
adaptations in order to contemplate both arterial and venous blood inputs of the liver. 
This work aims to develop and implement a software for parametric quantification of 
perfusion in the liver using a dual-input one-compartment model. Software 
implementation uses Matlab and it is organized in a series of steps that go from reading 
raw MRI data to calculating liver perfusion parametric maps. Software tests were 
conducted in a patient population with hepatocellular carcinoma. Results indicate that 
the proposed model is able to determine perfusion parameters and is sensitive to the 
detection of perfusion alterations. Standard image acquisition protocols must be used in 
the future in order to extend model application to larger clinical populations. 
Keywords: magnetic resonance imaging, liver perfusion, Tofts model, dual-input 
one-compartment model, hepatocellular carcinoma 
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Resumo 
A imagem de perfusão é uma técnica que permite a deteção de alterações 
regionais e globais do fluxo sanguíneo de um órgão e pode ajudar a prever o 
aparecimento de muitas doenças, nas quais a hemodinâmica do órgão se encontra 
modificada. A capacidade de manipulação do contraste da imagem através do uso de 
agentes de contraste exógenos faz da imagem por ressonância magnética (IMR) uma 
técnica amplamente utilizada para a avaliação não-invasiva da perfusão sanguínea no 
fígado. No entanto, a avaliação precisa da perfusão hepática permanece controversa 
relativamente aos diversos modelos matemáticos que podem ser usados para quantificar 
a perfusão. A maioria dos programas comercialmente disponíveis determina a perfusão 
no fígado com base no modelo Tofts, um modelo clássico e muito utilizado. Este é um 
modelo compartimental que assume troca do agente de contraste entre dois 
compartimentos - plasma sanguíneo e tecido - e que existe apenas uma entrada através 
da qual o contraste atinge o órgão, bem como uma saída. O modelo de Tofts tem de 
sofrer adaptações de modo a contemplar tanto a entrada de sangue arterial bem como 
a de sangue venoso que se verifica no fígado. Este trabalho pretende desenvolver e 
implementar um software para quantificação paramétrica da perfusão no fígado usando 
um modelo de duas entradas e um compartimento. O software em Matlab contempla o 
algoritmo desenvolvido num conjunto de passos, começando com a leitura dos dados 
não processados de ressonância magnética, terminando no cálculo dos mapas 
paramétricos das constantes cinéticas do agente de contraste e na perfusão total do 
fígado. Os testes do software foram realizados numa população com carcinoma 
hepatocelular. Os resultados indicam que o modelo proposto é capaz de determinar os 
parâmetros de perfusão e é sensível à deteção das alterações de perfusão. Protocolos 
de aquisição padrão devem ser utilizados no futuro a fim de estender a aplicação do 
modelo para populações clínicas maiores. 
Palavras-chave: imagem por ressonância magnética, perfusão do fígado, modelo de 
Tofts, modelo de duas entradas e um compartimento 
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Chapter 1  
Introduction 
1.1 Motivation and objectives 
The liver is an organ with a well-defined vascular structure. There are many 
hepatic perfusion disorders that induce modifications to the normal liver blood supply. 
Perfusion imaging of the liver is a quantitative imaging method that reflects the 
microcirculatory status of hepatic parenchymal and hepatic lesion blood flow. It is used 
in the clinical evaluation of several hepatic disorders such as cirrhosis or hepatocellular 
carcinoma (HCC). In the latter case, perfusion studies play an important role in e.g. 
detection of the primary tumor and metastases, evaluation of tumor viability or 
assessment of the effectiveness of antiangiogenic therapies. 
One of the major advantages of magnetic resonance imaging (MRI) is its wide 
range of imaging contrasts that provide, noninvasively, valuable information over the 
anatomy and function of the human body. The use of an exogenous contrast agent (CA) 
further enhances the flexibility of MRI to detect and study perfusion conditions.  
The evaluation of perfusion with MRI is achieved through the analysis of dynamic 
imaging data with mathematical models that describe the temporal evolution of the 
contrast agent concentration. By comparing the model predictions with the 
experimental data, it is possible to calculate the kinetic parameters that describe the 
transport of the contrast agent from the vascular bed to the extravascular extracellular 
space and vive-versa. Through the calculation of kinetic parameters one can evaluate 
perfusion and thereby identify potential biomarkers of disease.  
The evaluation of hepatic perfusion with MRI is possible with commercially 
available software. However, the central question here is that the mathematical models 
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that are implemented in these software packages generally follow the classic approach 
as proposed by Tofts and co-workers [1], which assumes the exchange of contrast agent 
between two compartments with a single input. The latter does not accurate describe 
the real vascular architecture of the liver and do not take into account the input of blood 
from the portal vein and consider the blood input to the liver to be mainly arterial. 
The present work aims to develop and implement a software for parametric 
quantification of perfusion using contrast enhanced MRI (CE-MRI) data acquired at 3T 
and using a gadolinium (Gd) based contrast agent. A dual-input one-compartment model 
is considered, which takes into account the dual input from both venous and arterial 
blood vessels, thus better reflecting the real liver blood supply. 
The present thesis consists of three main parts. The first part introduces the 
main concepts of MRI - physics of signal generation, image contrast mechanisms, image 
acquisition and reconstruction and basic pulse sequences. In this section, a review of the 
existing models for hepatic perfusion is also presented. The second part of the thesis 
describes the algorithm that was created to analyze hepatic CE-MRI data with the dual-
input single compartment model and the strategy that was followed for software 
implementation. The third and last part of this work was the validation, in which the 
developed software was tested in a population with HCC. 
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1.2 Liver: a brief view of anatomy and functions 
The liver is a reddish brown tubular gland located immediately under the 
diaphragm, filling most of the right hypochondriac and epigastric regions. The under 
surface faces the stomach, the first part of the duodenum and the right side of the large 
intestine (figure 1.1) [2, 3]. It is the second largest organ in the human body (second to 
skin) and the largest internal organ weighting approximately between 1.2 𝐾𝑔 to 1.8 𝐾𝑔 
in an adult human [4]. 
 
Figure 1.1: Location of the liver. Adapted from [3]. 
Anatomically the liver has four lobes: the right, left, quadrate and caudate lobes 
but usually there is a gross division in the two main lobes (left and right) by the falciform 
ligament (figure 1.2) [3]. 
 
Figure 1.2: General anatomy of the liver. a) Anterior aspect. b) Posterior aspect. Adapted from [2]. 
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 At the microscopic level, the functional units are represented by cylindrical 
structures with about 2 𝑚𝑚 long by 1 𝑚𝑚 in diameter called hepatic lobules. A lobe 
consists of a central vein passing down its core, surrounded by radiating sheets of 
cuboidal cells called hepatocytes. Each corner of the lobule usually contains a portal area, 
a complex composed of branches of the portal vein, hepatic artery, bile duct and nerve. 
Between the radiating rows of cells there are dedicated blood channels called sinusoids, 
which transport blood of the portal vein and hepatic artery. The sinusoids are lined by 
a fenestrated endothelium with fenestrations so large so that the hepatocytes are in 
direct contact with the blood. The blood flows from the portal area in the sinusoids and 
then to the central vein, which drains it from the lobule to the hepatic vein [2, 3].  
Thought it lies outside the digestive tract, the liver plays a key role not only to 
digestion but also to the proper functioning of the human organism.  Only one of the 
liver main functions contributes directly to the digestion: the secretion of bile. Other 
liver head functions are the regulation of the blood glucose levels, lipid synthesis (as 
lipoproteins, cholesterol and phospholipids), the removal of certain protein metabolism 
residues (like the NH2 groups), storage of vitamins (A, D, E, K and B12) and minerals 
(such as iron and copper) [2, 3]. 
 
1.2.1 Normal and Abnormal Liver Circulation 
The liver is a highly vascularized organ (figure 1.3) characterized by a dual blood 
supply consisting of the portal vein, which is the major supplier, contributing with about 
75% of the blood input, and the hepatic artery with the remaining 25% of blood input to 
the liver [5]. The hepatic artery supplies the liver with oxygenated arterial blood, while 
the hepatic portal vein drains venous blood from the entire gastrointestinal tract 
containing the nutrients absorbed by the small intestine. The output blood function is 
performed by the hepatic vein that drains blood from the liver into the inferior vena 
cava. There are also bile ducts which collect bile from the liver cells [2]. 
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Figure 1.3: Liver circulation network. Bile Ducts, Portal Vein and Hepatic Artery ramifications throw the liver 
parenchyma. Adapted from [6]. 
 
The arterial and venous supplies to the liver are not independent systems. Both 
of them provide blood, at different times, to the low pressure-sinusoids. These are lined 
with highly fenestrated endothelial cells, flanked by the hepatocytes in the liver cords 
(figure 1.4a). A nutrient-laden venous blood from the intestines and freshly oxygenated 
arterial blood from the celiac trunk is therefore delivered to the hepatocytes [3].  
This anatomical arrangement allows therefore the plasma to flow freely through 
the sinusoidal endothelial cells into the small interstitial space between sinusoidal 
endothelium and hepatocytes, known as the Space of Disse. Under normal conditions, 
the large size of the sinusoids’ fenestrae allows free exchange of low-molecular-weighted 
compounds between the plasma sinusoids and the interstitial Space of Disse (figure 1.4b). 
After filtering through the sinusoids, this blood collects in the central vein and drains to 
the hepatic veins which lead to the inferior vena cava [7]. 
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Figure 1.4: a) Microscopic anatomy of a six-sided lobule with arrows indication the direction of blood flow (adapted 
from [7]). b) Representative diagram of the microanatomic relationship of blood cells within sinusoid, fenestrated 
endothelial cells, plasma (p), the Space of Disse and the hepatocyte (adapted from [6]). 
In abnormal situations, more particularly in liver tumours such as hepatocellular 
carcinoma and metastases, there are relative changes in arterial and portal blood supply.  
Initially the blood supply from the liver to the tumor is due to the proliferation 
of the sinusoidal cells that become capillarized with loss of fenestrae and with the 
formation of basement membrane. As the tumor continues to grow and developing 
metastases, there is a combined process of recruitment of new blood vessels to the 
tumor region, supplied by the hepatic artery, which is called neoarteriogenesis. These 
modifications lead to a significant barrier to the free passage of low-molecular-weighted 
compounds between the plasma and the tumor region [5]. This feature is helpful in the 
way that such changes may be reflected in the hepatic enhancement kinetics of low-
molecular-weighted contrast agents used in some imaging techniques like the dynamic 
contrast-enhanced magnetic resonance imaging (CE MRI) [8]. 
 
1.2.2 Hepatocellular Carcinoma  
The Hepatocellular Carcinoma (HCC) is one of the most common, 
corresponding to approximately 70 – 80% of all liver tumors. The poor prognosis and 
late detection causes this to be the third-leading cause of cancer-related death 
worldwide. This is an aggressive cancer with a poor survival rate, being the incidence 
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almost equal to the death rate, responsible for approximately 600.000 deaths annually 
all over the world [6, 9, 10].  
1.2.2.1 Global Variation and Incidence 
HCC incidence keeps increasing with a unique geographic, sex and age 
distribution. Data analysis from large patient populations is a useful tool to study possible 
causes and trends. Looking to age-standardized incidence cases of HCC grouped by 
region and gender (figure 1.5), it is possible to notice that areas corresponding to ‘very 
high’ and ‘moderately high’ incidence include China, southeastern Asia, sub-Saharan 
western and eastern Africa. In most developed parts of the world, including Europe and 
North America, the incidence is very low with exception of Southern Europe and Japan. 
It is also noted a curious characteristic of the disease: higher incidence in men than in 
women [9, 10].  
 
Figure 1.5: Global variation in HCC incidence rates for the year of 2002. Classification was based on data in males 
being ‘Very high incidence’>20 per, ‘Moderately high incidence’ between 11 and 20, ‘Intermediate incidence’ between 
5 and 10 and ‘Low incidence’<5, all per 100.000. Adapted from [10]. 
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1.2.2.2 Risk Factors and Epidemiology 
The HCC is a complex malignancy with associated risk factors. In most cases 
there is a close relation with previous episodes of chronic infections such as viral or 
alcoholic liver disease [10, 11]. Within the main risk factors are: 
 Hepatitis Viruses: The vast majority of primary liver tumor (75 – 80 % of the 
cases) originate from viral infections: either from hepatitis B virus (HBV) or from 
hepatitis C virus, being the HBV more frequent [11]. 
 
 Alcohol:  Chronic alcohol abuse and alcoholic cirrhosis are known risk factors 
to HCC. The threshold dose and the exposure time that may lead to the disease 
are unknown. One of the hypothesis alcohol related HCC is that alcohol acts as 
a carcinogenic cofactor in the presence of HBV or HCV infection [9, 11]. 
 
 Nonalcoholic Steatohepatitis (NASH): The exact incidence of HCC in patients 
with NASH is also unknown. However there is a close positive correlation of 
the incidence of HCC with obesity and diabetes. These two conditions are 
usually related to the development of NASH, an increasingly recognised cause of 
cirrhosis, the latter representing one of the main risk factors for the development 
of HCC [11, 12]. 
 
 Chemical carcinogens: There is a close relationship between the exposure to 
aflatoxin B1 and the development of HCC. Aflatoxin is natural chemical 
carcinogen, produced by the Aspergillus fungus, which can be found in stored 
grains (such as peanuts and rice) in hot humid places. Aflatoxin contamination of 
food relates well with the incidence rates in Africa and China. There are other 
carcinogens that can also be responsible for the increased incidence of HCC like 
pesticides and insecticides seen in the middle East [6, 9]. 
 
 Other conditions: Metabolic disorders (like hemochromatosis and Wilson’s 
disease), chronic autoimmune liver diseases and several other underlying 
conditions have a less common association to de appearance of HHC.  However, 
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they should be taken into consideration since they can be considered risk 
conditions. In any case, etiology of HCC in most patients who do not have 
cirrhosis or viral infections is still unclear [6, 11]. 
  
1.2.2.3 Screening, surveillance and diagnosis 
Liver cancers may often escape clinical recognition due to the fact that they often 
arise in patients with cirrhosis. Symptoms attributed to the emergence of the disease 
are usually absent and, when present, are not specific of HCC. Among other complaints 
are: abdominal and epigastric pain, weight loss, early food satiety, nausea and abdominal 
swelling. As the evolution of the disease is usually fast and fatal, most patients are 
diagnosed at a stage when the disease is already advanced. As a consequence, the 
hypothesis of using curative therapies is precluded [11, 13]. 
Periodical surveillance is therefore recommended for those patients considered 
to be at high risk of developing HCC. The assumption is that early detection may lead 
to timely therapeutic intervention and to the decrease of associated mortality.  
The most common screening methods of HCC are the serologic evaluation of 
alpha-fetoprotein (AFP) and abdominal ultrasonography (US). Despite of the low 
sensitivity (≈ 60%), US has great specificity (>90%) in the detection of HCC nodules. 
Continuously high levels AFP (>500 ng/mL) are known to be associated with the presence 
of the disease. Due to the low sensitivity of this serologic screening test, it is often 
associated with US, to increase the reliability of the diagnosis [11]. 
The modalities of diagnosis depend both on the lesion size and on the underlying 
liver function. The detection of liver lesions that are larger than 1 𝑐𝑚, using the above 
mentioned techniques justify the requirement for cross-sectional imaging techniques. 
Blood supply of HCC lesions is different from the surrounding healthy hepatic 
parenchyma, being that the tumor is supplied by the hepatic artery whereas healthy 
parenchyma is essentially supplied by the portal vein. Based on this, the use of helical 
computed tomography (CT) and CE-MRI have been establishing a classic image profile 
of HCC lesions, through the differences between the enhancement profiles of lesions 
Chapter 1 - Introduction   10 
 
 
and healthy parenchyma [11]. In fact, tumor regions not only have early enhancement 
relatively to the remaining hepatic parenchyma, but they also have a faster washout of 
the contrast agent. 
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Chapter 2   
Perfusion Studies of the Liver using MRI 
2.1 Magnetic Resonance Imaging 
2.1.1 Fundamentals 
MRI is a versatile imaging technique whose name derives from the Nuclear 
Magnetic Resonance physical phenomenon in which, through the combination of strong 
magnetic fields and radiofrequency signals, it is possible to manipulate the precession 
movements of atoms with intrinsic magnetic susceptibility [14]. With this imaging 
modality it is possible to create images of biologic tissues that can be used for biomedical 
purposes. 
  Atoms that have an odd number of protons or neutrons like hydrogen, carbon-
13, fluorine, sodium and phosphorus, behave like a magnetic dipole having associated a 
magnetic dipole moment, or simply magnetic moment. This non-null magnetic moment 
interacts with external magnetic fields, allowing its use in MRI. Due the fact that 
approximately 70% of the human organism is made of water, the preferred imaging 
element is the hydrogen, composed by a single proton and electron. It can be found not 
only in free water, but also in macromolecules such as proteins and lipids [14]. 
Spin is a quantic property, characteristic of sub-atomic particles like protons. It 
can be seen as the gyratory movement of the proton around its axis. This movement 
creates a current loop which, in addition to creating a magnetic field itself, is capable of 
interacting with external magnetic fields [14, 15]. In the absence of an external magnetic 
field, the proton spins behave like small magnetic dipoles, with a magnetic moment µ⃗  of 
equal magnitude and are randomly oriented in space. When exposed to a static magnetic 
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field 𝐵0, they lign-up with the field direction with either parallel or anti-parallel 
orientations. However, there is a small excess of spins aligned parallel to the magnetic 
field, when compared to those aligned anti-parallel to 𝐵0. Furthermore, the relative 
excess of spins depends on factors such as 𝐵0 magnitude and absolute temperature. As 
a consequence, at normal body temperature and for the typical values of 𝐵0 available in 
clinical scanners, the net magnetization in equilibrium ?⃗⃗? 0 will be aligned parallel to 
𝐵0[14–16]. 
 
Figure 2.1: Randomly orientated spins (left) align when exposed to strong external magnetic field, presenting parallel 
or antiparallel orientations (right). Adapted from [17]. 
 
Spins describe a precession movement around the axis defined by 𝐵0. The 
precession frequency 𝜔0, also known as Larmor frequency [15], depends on the 
gyromagnetic ratio 𝛾 and on the strength of the external magnetic 𝐵0, according to: 
𝜔0 =  𝛾 𝐵0  
2.1 
As the net magnetization ?⃗⃗?  contains potential energy, the intentional 
perturbation of the equilibrium state generates of a measurable signal. Hence, by applying 
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energy through a radiofrequency magnetic field (𝐵1) for a short time, i.e., a 
radiofrequency (RF) pulse with frequency equal to the Larmor frequency (𝜔𝑅𝐹 = 𝜔0), 
a resonance condition is established. In this condition, spins absorb energy from the RF 
pulse which causes spins to increase their precession angle. This implies that the net 
magnetization is tipped away from the longitudinal axis, thus creating measurable 
magnetization, spinning on an axis perpendicular to 𝐵0 and to 𝐵1. In this way, two 
magnetization components are obtained: the longitudinal ?⃗⃗? 𝑍 and the transverse ?⃗⃗? 𝑇, 
parallel and perpendicular to 𝐵0, respectively [14, 15, 17]. 
 
Figure 2.2: Flip of the net magnetization by 900 after spin excitation with an RF pulse at the Larmor frequency. 
Adapted from [17]. 
 
Once the RF is removed, spins tend to come back to its previous equilibrium 
state through a process called relaxation, which results from the loss of the transmitted 
RF energy due to the interaction of the nucleus with the system. While ?⃗⃗? 𝑍 recovers to 
its initial equilibrium state (longitudinal relaxation), ?⃗⃗? 𝑇 returns to zero, at a different 
rate [14, 16]. The magnetization variation, which results from both transverse and 
longitudinal relaxations, generates the RF signal that is received by coils within the MR 
scanner. This signal will give information related to the nucleus environment and, if 
properly encoded, will also give structural information [16]. 
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2.1.2 Relaxation effects and Bloch Equation 
After excitation, spins release the absorbed energy, thus returning to the initial 
state through relaxation. The latter consists of longitudinal and transverse relaxation 
processes [18].  
Longitudinal relaxation, or spin-lattice relaxation is directly related to the 
realignment of the longitudinal magnetization with the external magnetic field by the 
liberation of energy to the surroundings. The constant 𝑇1 is defined as the time that is 
necessary for the system to recover approximately 63% of the original ?⃗⃗? 𝑧. The values 
of 𝑇1 constant, which vary with 𝐵0 intensity and with the type of biologic tissue, can go 
from hundred to thousands of milliseconds. The cerebrospinal fluid (CSF), blood and 
grey matter present the highest 𝑇1 values that can be found in the human body, being 
the lower ones correspondent to fat [15–18]. 
Transverse relaxation, or spin-spin relaxation originates from the loss of phase 
coherence of precessing spins in the transverse plan. Spins have different Larmor 
frequencies induced by local field inhomogeneities which decrease transverse 
magnetization and lead to a reduction of signal intensity. This relaxation process is 
characterized by the 𝑇2  time constant, defined as the time that elapses until the signal 
originated from transverse magnetization has reached 37% of its initial value. The values 
of 𝑇2 time constants also depend on the magnetic field strength and on the biological 
tissue and are always smaller than 𝑇1 values [15–18]. 
 
Figure 2.3: Relaxation processes. Alignment of the net magnetization with the external magnetic field in longitudinal 
relaxation (upper row). Dephasing of precessing spins in transverse relaxation (lower row). Adapted from [17]. 
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The presence of local variations in the external 𝐵0 magnetic field induces a 
distinct mechanism of transverse relaxation, which is described by the time constant 
𝑇2′. As a consequence, the transverse relaxation time in this situation i.e. 𝑇2∗, results 
from the sum of the spin system contribution and that of 𝐵0and is given by [15]: 
1
𝑇2∗ 
=  
1
𝑇2
+ 
1
𝑇2′
 
2.2 
In the presence of both longitudinal and transverse relaxations, the variation of 
𝑀𝑧 and 𝑀𝑇 is respectively given by [15]: 
𝑑𝑀𝑧
𝑑𝑡
=  
1
𝑇1
 (𝑀0 − 𝑀𝑧) 
2.3 
And 
𝑑?⃗⃗? T
𝑑𝑡
=   𝛾 ?⃗⃗? T × ?⃗? 0 − 
1
𝑇2
 ?⃗⃗? T 
2.4 
The combination of differential equations 2.3 and 2.4, yields the temporal 
variation of net magnetization vector ?⃗⃗? : 
𝑑?⃗⃗? 
𝑑𝑡
= 𝛾 ?⃗⃗? 𝑇 × ?⃗? 0  +   
1
𝑇1
 (𝑀0 − 𝑀𝑧)?̂?  −  
1
𝑇2
 ?⃗⃗? T 
2.5 
The differential equation in 2.5 is known as the Bloch equation and it describes 
the behaviour of the net magnetization vector in the presence of relaxation effects and  
for an external magnetic field 𝐵0 pointing along the ?̂?-axis [15]. 
Chapter 2 – Perfusion Studies of the Liver using MRI  16 
 
 
2.1.3 Spatial Encoding - Image Formation 
Spatial Encoding is the process by which the information from the detected signal, 
which varies in time, is transformed into signal variation in space. Through the application 
of field gradients, the resonance frequency changes according to: 
𝜔 (𝑥) =  𝛾 𝐵(𝑥)  
2.6 
Where 𝑥 corresponds to the spatial coordinate along the gradient field direction 
and 𝐵(𝑥) is the magnetic field in 𝑥 position [15]. 
Based on equation 2.6, spectral frequencies will represent the spatial information 
since they will vary in space according to the prescribed magnetic field gradients. Using 
a signal processing tool like the inverse Fourier Transform (FT) it is possible to 
reconstruct the signal and create images from the spectrum of detected frequencies [16, 
17]. Spatial Encoding is processed using field gradients in three orthogonal directions: 
Slice selection gradient (Gss); Phase encoding (Gpe) and Frequency encoding/Readout 
(Gro) gradient [16, 17].   
For a given slice to be imaged, a magnetic gradient is added along the slice 
direction. Due to this spatial variation of the magnetic field, each nucleus will have a 
Larmor frequency dependent of its position, making possible the selective excitation of 
a thin slice to be imaged [15–17]. To obtain information for the individual points (pixels) 
within a slice, the Gro and Gpe are used enabling the encoding of both spin frequency 
and phase, respectively. During phase encoding, a temporary gradient is applied between 
the RF excitation pulse and the readout, causing a shift in the phase of the precessing 
nuclei. Changing the amplitude of the temporary gradients, it is possible to acquire signals 
with different phase encodings [15–17]. The Gro (frequency encoding in x-direction) is 
used to distinguish pixels within the same phase encoding. This gradient is applied during 
the readout of the signal and results in a specific shift of the resonance frequency for 
pixels with the same phase shift [15–17]. The phase and frequency information are 
stored in the k-space (figure 2.4), where each row corresponds to the frequency 
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information and each column corresponds to the phase information. Image 
reconstruction is performed by calculating the 2D (or 3D, if pure three dimensional 
acquisition) inverse Fourier Transform (FT) of the samples gathered in k-space [14].    
 
Figure 2.4: K-space representation where each pixel corresponds to a specific phase and frequency combination. 
Adapted from [17]. 
 
2.1.4 Pulse Sequences 
MRI uses pulse sequences (RF pulses interleaved with gradients pulses) to obtain 
images. Through the manipulation of the type, timing and duration of the pulse sequence 
elements, it is possible to generate different image contrasts (e.g. choosing between 𝑇1  
or 𝑇2 weighting) thus potentially increasing the specificity of the study. It is therefore 
important to tune three parameters involved in the manipulation of pulses sequences: 
the time between two consecutive RF pulses, known as repetition time (𝑇𝑅), the time 
between the excitation pulse and the measurement of maximum signal, called echo time 
(𝑇𝐸) and the flip angle (𝜃) defined as the angle by which the magnetization is tipped away 
from 𝐵0 by the application of the RF pulse [15]. 
There are two main families of pulse sequences: Spin-Echo (SE) and Gradient-
Echo (GRE) [15].  
Spin-echo sequences (figure 2.5) are characterized by the application of an RF 
pulse that flips the magnetization 90o from its equilibrium direction followed by a 180o 
refocusing pulse applied at 𝑇𝐸/2 and the process is repeated after a certain 𝑇𝑅 [18, 19]. 
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Figure 2.5: Spin-echo sequence scheme made up of a series of events: 90° pulse – 180° rephasing pulse at 𝑻𝑬/𝟐 – 
signal reading at 𝑻𝑬. This series is repeated at each time interval 𝑻𝑹. Adapted from [17]. 
 
Gradient-echo sequences (figure 2.6) differ from the spin-echo sequences 
because they do not use the 180o refocusing pulse and flip angles are usually lower than 
90o. Instead of the 180o RF pulse they use a reversal of magnetic field gradients for 
magnetization refocusing and signal generation. A bipolar readout gradient (frequency-
encoding gradient) is required to create an echo. The gradient echo formation results 
from applying a dephasing gradient before the frequency-encoding or readout gradient. 
Generally these type of sequences with low-flip angle excitations are faster than the spin-
echo sequences, allow new contrasts between tissues (e.g. 𝑇1/𝑇2) and the resulting 
images can be weighted on 𝑇1 or 𝑇2 [18, 19]. 
In this work, the type of pulse sequence that is used to acquire data belongs to 
the gradient-echo type. The effects of 𝑇2∗ have to be minimized in order to obtain 𝑇1-
weightening. The choice of a very short 𝑇𝐸 reduces any 𝑇2 contrast such that: 
𝑇𝐸 ≪ 𝑇2 ⇒ 𝑒−
𝑇𝐸
𝑇2∗ → 1  
2.7 
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Figure 2.6: 2-D spoiled gradient-echo scheme. In the absence of the 180o pulse, the polarity of Gro dephasing 
gradient pulse is opposite to the readout gradient pulse applied. Adapted from [17]. 
 
2.2 Perfusion Imaging 
Perfusion imaging can be defined as a quantitative imaging method that is used to 
evaluate regional and global modifications in the blood flow of an organ. Since 
modifications in both arterial and venous blood supplies can predict the onset of disease, 
hepatic perfusion studies are endowed with great utility as they allow the increase of 
sensitivity and specificity in disease diagnosis [7, 8].  
There are several critical points to perform perfusion studies [7]: 
 High spatial and temporal resolution to identify perfusion differences in 
small tumors and record the passage of contrast agent, respectively. 
These two demands are often conflicting. 
 Good image tracer in order to obtain accurate perfusion quantification. 
 Proper tracer kinetic modelling methods for accurate calculation of 
perfusion parameters. 
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 Whole liver imaging enabling tumor surveillance. 
 
2.2.1 CE – MRI for hepatic perfusion study 
Despite the existence of various techniques to study blood perfusion, MRI 
emerges as an interesting one. In fact, this is a high spatial and temporal resolution 
technique that provides anatomical information, does not make use of ionizing radiation, 
has good sensitivity for tumor detection and can be combined with other imaging 
techniques, like positron emission tomography (PET), in order to obtain complementary 
information [8]. 
Among several MRI methods to study blood perfusion (arterial spin labelling – 
ASL [8], for example), the technique which has been established as the gold standard for 
hepatic perfusion is CE – MRI. It involves the injection of a contrast agent with 
subsequent MR signal acquisition over time. The signal temporal variation shows the 
uptake rate of contrast in tissues and its subsequent washout [8]. 
Contrast agents used in MRI have different magnetic properties that affect 
hydrogen atoms in water molecules, causing changes to the measured signal. They are 
used in order to improve both specificity and image signal-to-noise ratio (SNR). The vast 
majority uses chelates containing paramagnetic atoms having one or more unpaired 
electrons, creating a strong electronic magnetic moment [20]. Gadolinium, a chemical 
element of symbol Gd and atomic number 64, is one of the paramagnetic agents that is 
most used in MRI contrast agents. It has large paramagnetic susceptibility and rapidly 
redistributes into the extracellular space, thus making it a good contrast agent for 
perfusion studies. The local magnetic field created by the Gd chelates can relax the 
magnetic state of the hydrogen atoms, causing modifications in their 𝑇1  relaxation times. 
Causing 𝑇1  shortening there will be enhanced signal on post-contrast 𝑇1-weighted 
images in those regions with highest contrast agent uptake. The pharmacokinetic 
behavior of the contrast agent is usually defined by the compound chelated to the 
paramagnetic atom [20]. 
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Liver imaging in CE-MRI uses a dynamic fast MRI sequence, capable of picking up 
local alterations, which results from the passage of the contrast agent through the liver. 
Since gadolinium is paramagnetic and leads to the shortening of 𝑇1, 𝑇1-weighted 
sequences are used. Usually, a fast 𝑇1-weighted spoiled gradient echo sequence is used 
to acquire the dynamic data series after contrast injection, with coronal or sagittal views 
[20]. Subsequently, acquired images will show enhancement in areas where contrast was 
delivered to the tumor [8, 20].  
2.2.2 Liver perfusion information from MRI data 
Once acquired, MRI data must be analysed in order to extract meaningful 
vascularity information. The method of analysis depends on factors such as the pulse 
sequence that is used to acquire data, and the goal of the hepatic perfusion studies. 
Dynamic MRI data can either be processed using model-free or model-based 
approaches. Whereas a model-free approach is easier to implement, the results it yields 
are site dependent as they depend on the MR scanner, the model-based method is more 
attractive because it gives quantitative information of tissue vascular properties, by using 
mathematical models that reflect the underlying pathophysiology [8]. Furthermore, the 
quantification is independent of the MR scanner that was used in data acquisition. 
 
 
 
 
 
 
 
Chapter 2 – Perfusion Studies of the Liver using MRI  22 
 
 
 
Chapter 3 – Materials and Methods   23 
 
 
Chapter 3   
Materials and Methods 
3.1 Perfusion Models 
The calculation of perfusion parameters is accomplished through the model-
based analysis of MRI data. The use of mathematical models to study vascular leakage 
and permeability is not a new technique. It had been first used to study perfusion of the 
functional state of the blood-brain barrier (BBB) in multiple sclerosis disease and brain 
tumors, as well in retinal disease and breast tumors [1, 21]. With the increase of 
perfusion studies, several different models have been developed, based on the 
quantitative analysis of a dynamic curve of signal enhancement versus time from a specific 
ROI. The versatility of parameter extraction is based on the fact that different model 
assumptions, reflecting the underlying physiological conditions, can be made. 
The most  commonly used and well accepted model reflecting the kinetics of low 
molecular Gd-chelates is the Tofts Model [21].  This is a compartmental model based 
on the following assumptions [1, 21, 22]: 
 Compartments contain the contrast agent in a uniform concentration in all their 
extension; 
 There is an intercompartment flux, which is proportional to the difference of 
contrast concentration between the compartments; 
 Blood-Plasma compartment, characterized by a contrast concentration 𝐶𝑃 (mM 
liter-1); 
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 An Extravascular Extracellular Space (EES) compartment, with volume 𝑣𝑒  per unit 
of tissue and tracer concentration 𝐶𝑒. 
This is a two-compartment one-input compartmental model, as figure 3.1 shows. 
Tofts model assumes contrast exchange between two compartments: the Blood plasma 
and the Tissue with only one vascular input (derived only from hepatic artery, in the 
liver situation) and one output. There is a main kinetic constant, the transfer constant - 
𝐾𝑡𝑟𝑎𝑛𝑠 (𝑚𝑖𝑛−1) - that reflects the volume transfer between the plasma (of volume 𝑣𝑃) 
and the EES (of volume 𝑣𝑒). 
 
Figure 3.1: Schematic representation of the Tofts model. Based on [25]. 
Although the Tofts model is well established and used by most commercial 
software packages for perfusion assessment, the fact is that it is does not reflect the real 
vascular architecture of the liver. This work aims to implement a software for the 
calculation of liver perfusion parametric maps using a mathematical model that more 
closely reflects the real vascular architecture of the liver. The proposed model consists 
of a dual-input one-compartment model, comprising both arterial and portal blood input 
to the liver. 
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3.1.1 Dual-input one-compartment model 
The Tofts model relies on the fact that the blood input is mainly arterial. This 
assumption, proved to be wrong in the liver situation, which leads to the necessity of a 
new formulation in order to produce an accurate calculation of liver perfusion 
parameters. 
A dual-input one-compartment model [23] is presented (figure 3.2). This model 
reflects the dual input blood flow with two different first-order inflow rate constants: 
𝑘1𝑎 from the hepatic artery and 𝑘1𝑝 from the portal vein, and a single first-order outflow 
rate constant 𝑘2.  It is assumed that there is only one compartment corresponding to 
the liver. Vessels, capillaries, extravascular space hepatic cells are considered to be a 
single compartment. This assumption can be made because most diffusable contrast 
agents pass from the capillaries into the extracellular extravascular space, where it 
remains, until elimination occurs, not being absorbed by hepatocytes. It should be 
noticed however that for certain types of contrast agents, such as Gd-based contrast 
agents, this assumption does not hold because the contrast agent is taken in by the 
hepatocytes. If the purpose of the study was the assessment the functionality of liver 
cells instead of blood perfusion, a model with more than one compartment would be 
appropriate. 
 
Figure 3.2: Schematic representation of the dual-input one-compartment model for liver perfusion. Based on [23] 
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𝐶𝑎(𝑡), 𝐶𝑝(𝑡) and 𝐶𝐿(𝑡) represent the concentration of the tracer form the aorta, 
the portal vein and the liver compartments, respectively. From this model, the temporal 
variation of the contrast agent concentration in the liver is given by [23]: 
𝑑𝐶𝐿(𝑡)
𝑑𝑡
= 𝑘1𝑎𝐶𝑎(𝑡) + 𝑘1𝑝𝐶𝑝(𝑡) − 𝑘2𝐶𝐿(𝑡)  
3.1 
In this model, perfusion is quantified according to the following equations: 
 𝑃𝑎 = 
𝑘1𝑎
𝐸
 3.2 
 𝑃𝑝 = 
 𝑘1𝑝
𝐸
 3.3 
 𝑃𝐿 = 
𝑘1𝑎+ 𝑘1𝑝
𝐸
 3.4 
Where 𝑃𝑎 , 𝑃𝑝 and 𝑃𝐿 are the arterial, portal and liver perfusion usually presented 
in the literature with units of 𝑚𝑖𝑛−1and 𝐸 has no units and represents the extraction 
fraction of the contrast agent in the liver. 
 
3.2 Data acquisition 
3.2.1 Patient Selection and Image Acquisition 
CE - MRI data from 5 patients (4 male and 1 female), diagnosed with HCC, were 
used. Participants were included between September 2013 and May 2014 with data 
acquisiton performed twice: before treatment and after aproximately 3 months of a 
treatment with Sorafenib. Sorafenib is an approved drug for the treatment of HCC as 
well as renal cell and radioactive iodine resistant advanced thyroid carcinomas. It is a 
multikinase inhibitor that blocks the receptor tyrosine kinases VEGFR (Vascular 
Endothelial Growth Factor Receptor) and PDGFR (Platelet Derived Growth Factor 
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Receptor) co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar. Sorafenib 
treatment induces autophagy, which is a process that may lead to tumor growth 
suppression [24]. 
Gadovist, Gd-DO3A-brutol (figure 3.3), was the nonionic paramagnetic agent 
used for tissue contrast enhancement during the signal acquisiton. It is eliminated by the 
kidneys [25]. 
 
Figure 3.3: Gadovist chemical structure. It is a macrocyclic neutral Gd-chelate [25]. 
Images were acquired on a 3T whole-body MRI scanner (Siemens MagnetomTrio, 
Erlangen, Germany). 
CE images were acquired for each patient with a 3D 𝑇1-weighted spoiled 
gradient-echo in the coronal plane. Additional pulse sequence parameters are shown in 
𝑡𝑎𝑏𝑙𝑒 1. Data from each patient consists of a set of 50 dynamics with a specific duration, 
defined by the temporal resolution, in which the first four/five correspond to the baseline 
signal from tissues without contrast and the remaining to the temporal variation of the 
signal after injection of contrast agent. In each dynamic, images of 20 slices are accquired, 
corresponding to coronal views of the abdominal region. These slices include different 
sections of the liver tumor, parenchyma and vessels. There was also the acquistion of 
pre-contrast scans with the same geometry and acquisiton plane of the dynamic scans, 
and where the flip angle was varied from scan to scan. Data acquired in the pre-contrast 
scans was used to determine the native 𝑇1 of tissues.  
Images were exported from the MR scanner in dicom format with a spatial 
resolution of 128 × 128 pixels.  
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Table 1: Pulse sequences parameters for the 3D 𝑻𝟏-weighted spoiled gradient-echo scans in both pre- and post-
treatment for all patients. 
Patient 
Nr 
Acq. Baseline 
Dynamics 
Temporal 
Resolution 
(ms) 
FOV 
(mm) 
Acq. 
Matrix 
In-plane 
spatial 
resolution 
(mm) 
Slice 
Thickness 
(mm) 
Flip 
Angle 
(o) 
TR 
(ms) 
TE 
(ms) 
1 
Pre 5 7857 320*320 128*128 2,50 3,60 25,0 5,80 1,12 
Post 10 7855 320*320 128*128 2,50 3,60 25,0 5,80 1,12 
2 
Pre 3 6433 380*380 128*128 2,97 3,60 24,0 4,75 1,68 
Post 4 6433 320*320 128*128 2,50 3,60 22,5 4,75 1,72 
3 
Pre 3 6433 400*400 128*128 3,13 3,60 24,0 4,75 1,68 
Post 4 7110 400*400 128*128 3,13 3,60 23,0 5,20 1,08 
4 
Pre 5 4850 350*350 128*128 2,73 3,60 25,0 3,58 1,10 
Post 5 5298 350*350 128*128 2,73 3,60 25,0 3,91 1,10 
5 
Pre 5 6813 320*320 128*128 2,50 3,60 25,0 5,03 1,72 
Post 5 6435 320*320 128*128 2,50 3,60 25,0 4,75 1,72 
 
3.3 Software implementation 
Software implementation was developed on Matlab R2012a® (The Math-Works, 
Inc., Natick, MA). ImageJ [26] and RadiAnt viewer [27] were auxiliary tools that were 
used to help visualizing image enhancement and defining regions of interest (ROIs). 
The algorithm for perfusion quantification was implemented as a sequential set 
of steps, starting with the images from the dynamic acquisition and ending on the 
perfusion parameters determination. The flowchart of figure 3.4 indicates the major 
steps of the implemented algorithm. 
The adopted strategy for calculating and displaying results was pixel mapping. 
This method gives perfusion information as maps spatially co-registered with the 
anatomical images on a pixel-by-pixel basis. Hence, a heterogenic appreciation of either 
the tumor regions or healthy parenchyma can be made, without losing information over 
the spatial variation of kinetic parameters, as it happens when considering a single ROI 
analysis. 
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Figure 3.4: Flowchart illustrating the major steps of the algorithm that was implemented to estimate perfusion 
parameters on a pixel-by-pixel basis, using a dual-input one compartmental model. 
 
3.3.1 ROIs definition 
One of the objectives of this work was to compute perfusion parameters as 
parametric maps, in order to be able to assess the spatial variation of kinetic parameters. 
In order to optimize computation time, ImageJ was used to draw ROIs of the structures 
of interest: hepatic artery, portal vein and liver. These ROIs were saved and imported 
to Matlab as masks. Kinetic parameter calculation was only performed in pixels within 
the masks, thus discarding pixels in structures of non-interest and in the background 
noise. 
It was necessary to determine 20 different ROIs of the liver for each patient, 
since each slice corresponds to different liver sections. Although ROI definition occurs 
with the data of a single dynamic and there are slight movements of the patient from 
dynamic to dynamic, the same ROIs were used in each of the fifty dynamics, thus 
assuming spatial correspondence over time. Although there are minor differences, these 
are minimized with the motion correction algorithm of the MR acquisition system.  
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Ideally, pre- and post-treatment acquisitions have the same geometry and cover 
the same slices. However, as can be observed from figure 3.5, in practice this situation 
does not happen and it was therefore necessary to define different ROIs for pre- and 
post-treatment.  
 
Figure 3.5: Liver ROIs of the same patient for the slice 13 drawn from the first temporal dynamic, corresponding to 
pre-treatment (left) and post-treatment (right). Differences in size, location and shape are highlighted. 
For the blood vessels, a single ROI was determined (figure 3.6), corresponding 
to the slice that would capture the best representation of ‘in-plane’ flow in the vessel.   
 
Figure 3.6: Abdominal aorta (red), used as substitute for the hepatic artery, and portal vein (blue) ROIs for the same 
patient. 
It should be stressed that the abdominal aorta was used as a surrogate for the 
hepatic artery since the latter is often difficult to visualize and segment. It is considered 
that they are similar in both 𝑇1 values and temporal variation of CA concentration. 
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Identification process of portal vein required the importation of the MRI data to 
Radiant viewer, which allowed the visualization of a fixed slice over the temporal 
dynamics and observe the contrast agent arrival to the liver. In order to precisely identify 
this structure, it was necessary to plot signal curves of pixels within the presumed ROI 
to confirm the existence of the enhancement peak after the baseline acquisitions. 
3.3.2 𝑻𝟏 Mapping 
The first step after the data has been corrected for motion is to determine the 
native 𝑇1 values of the tissues, i.e. performing 𝑇1 mapping. This is a necessary step to 
obtain parametric maps for the concentration of contrast agent for each dynamic 
acquisition. In order to perform 𝑇1 mapping, the variable flip angle method was applied. 
In this method, a series of 𝑇1-weighted scans are acquired at different flip angles but 
keeping all remaining acquisition parameters constant. In this way, it is possible to 
determine the 𝑇1 value of tissues from the image contrast variation from scan to scan 
(figure 3.7). 
 
Figure 3.7: Different signal intensities from 𝑻𝟏-weighted images with variable flip angles. For 𝑻𝟏 mapping 𝟐𝒐 (a), 𝟓𝒐 
(b), 𝟏𝟎𝒐 (c), and 𝟏𝟓𝒐 (d) were used. 
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The signal intensity in 𝑇1-weighted, considering a very small 𝑇𝐸 (𝑇𝐸 ≪ 𝑇2* 
approximation), for a given flip angle 𝜃, and 𝑇𝑅, is given by [28]: 
𝑆(𝜃) =  𝑀0sin (𝜃) 
1 −  𝑒−𝑇𝑅/𝑇1
1 − cos (𝜃)𝑒−𝑇𝑅/𝑇1
 
3.5 
Where 𝑆(𝜃) is the signal intensity for flip angle 𝜃, 𝑀0 represents the unknown 
longitudinal magnetization, and 𝑇𝑅 is the repetition time. Keeping 𝑇𝑅 constant, the signal 
intensity will only depend on 𝑇1 and 𝜃. Let  𝑎 =  𝑒−
𝑇𝑅
𝑇1 . In this case, equation 3.6 is 
rewritten as: 
𝑆(𝜃) =  𝑀0sin (𝜃) 
1 − 𝑎
1 − cos(𝜃) 𝑎
 
3.6 
Further manipulations allow the linearization of 3.7 as: 
𝑆(𝜃)
sin (𝜃)
= 𝑎 
𝑆(𝜃)
tan(𝜃)  
+  𝑀0(1 − 𝑎) 
3.7 
 
Where the independent variable is 𝑆()/𝑡𝑎𝑛() is the independent variable and 
𝑆()/𝑠𝑖𝑛() is the dependent variable.  The 𝑇1 values are straightforwardly determined 
by a linear fit of eq. 3.8 to the experimental pairs of values (𝑆()/𝑡𝑎𝑛(), 𝑆()/𝑠𝑖𝑛()): 
𝑎 =  𝑒−𝑇𝑅/𝑇1  ⇒  𝑇1 = −
𝑇𝑅
ln (𝑎)
 
3.8 
Considering a curve of signal intensity as a function of the flip angle (figure 3.8), 
keeping 𝑇𝑅 constant, for a given 𝑇1, there is an optimal flip angle to obtain the maximum 
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signal after a series of excitation pulse, called the Ernst angle [28]. In order to obtain an 
accurate 𝑇1 measurement it is important that the range of flip angles that are used in 
the measurements includes the Ernst angle (peak of the curve).  
 
Figure 3.8: Dependence of the signal intensity on the flip angle. The peak of the curve corresponds to the Ernst 
angle. Based on [28]. 
 
3.3.3 Contrast agent concentration conversion  
After the baseline 𝑇1 for a particular pixel is known, it is possible to determine 
the contrast agent concentration that led to signal enhancement in that pixel. The 
paramagnetic properties of the contrast agent accelerate the longitudinal relaxation 
process, i.e. 𝑇1 is shortened. In 𝑇1-weighted images the signal intensity is inversely 
proportional to 𝑇1 and the relaxation rate increases proportionally to the concentration 
of CA [21] according to: 
1
𝑇1
=  
1
𝑇10
+ 𝑟1𝐶 
3.9 
Where 𝑟1 is the relaxivity of the CA, a parameter that describes how 𝑇1 changes 
in the presence of a certain concentration of CA. The relaxivity of Gadovist has the 
value of 3,58 𝐿 𝑚𝑚𝑜𝑙−1𝑠−1 [29], and 𝑇1 and 𝑇10 are respectively the 𝑇1 values after 
and before contrast injection. 
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It was necessary to know how 𝑇1 varies over time depending on the 
concentration as a function of the variation of signal, i.e.: 
𝑇1(𝑡, 𝐶(𝑡)) =  𝑓 (
𝑆(𝑡)
𝑆(0)
) 
3.10 
Considering both the signal before - 𝑆(0) and after - 𝑆(𝑡) CA injection to be: 
𝑆(0) = 𝑀0𝑠𝑖𝑛𝜃 
1 −  𝑒−𝑇𝑅/𝑇10
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇10
 
3.11 
𝑆(𝑡) = 𝑀0𝑠𝑖𝑛𝜃 
1 −  𝑒−𝑇𝑅/𝑇1
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇1
 
3.12 
Their ratio in given by: 
𝑆(𝑡)
𝑆(0)
= 𝑀0𝑠𝑖𝑛𝜃 
1 −  𝑒−𝑇𝑅/𝑇1
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇1
×𝑀0𝑠𝑖𝑛𝜃 
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇10
1 −  𝑒−𝑇𝑅/𝑇10
 
1
𝑀0𝑠𝑖𝑛𝜃
 
3.13 
Considering  𝑦 =  
𝑆(𝑡)
𝑆(0)
 ,  𝑥 =  
1−𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇10
1− 𝑒−𝑇𝑅/𝑇10
 and 𝑎 = 𝑒−𝑇𝑅/𝑇1 , the previous 
equation comes as: 
𝑦 =  
1 −  𝑎
1 − 𝑎. 𝑐𝑜𝑠𝜃
× 𝑥 
3.14 
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Isolating the ‘𝑎’ parameter: 
𝑎 =  
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃
 
3.15 
And substituting ‘a’: 
𝑒−𝑇𝑅/𝑇1 = 
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃
  ⇔ −
𝑇𝑅
𝑇1
= ln (
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃
)  ⇔  𝑇1 =  
−𝑇𝑅
ln (
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃)
  
3.16 
There are two separate equations for 𝑇1. Combining them it is possible to have 
concentration over time given by: 
1
1
𝑇10
+ 𝑟1𝐶(𝑡)
=  
−𝑇𝑅
ln (
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃)
 ⇔  𝐶(𝑡) =
1
𝑟1
(
 
 
− ln(
𝑥 −  𝑦
𝑥 − 𝑦𝑐𝑜𝑠𝜃)
𝑇𝑅
−
1
𝑇10
)
 
 
   3.17 
Substituting  ‘𝑥’ and ‘𝑦’ in the equation, the concentration in (𝑚𝑀/𝐿) is given by: 
𝐶(𝑡) =
1
𝑟1
(
 
 
 
 
 
 
 
− ln
(
 
 
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇10
1 −  𝑒−𝑇𝑅/𝑇10
−
𝑆(𝑡)
𝑆(0)
1 − 𝑐𝑜𝑠𝜃𝑒−𝑇𝑅/𝑇10
1 −  𝑒−𝑇𝑅/𝑇10
−
𝑆(𝑡)
𝑆(0)
 𝑐𝑜𝑠𝜃
)
 
 
𝑇𝑅
−
1
𝑇10
)
 
 
 
 
 
 
 
 
3.18 
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Observing equation 3.19, the concentration will only depend on known 
parameters: the temporal variation of the signal after contrast injection, the signal 𝑆(0) 
before contrast injection, flip angle , relaxivity 𝑟1 of the CA, repetition time TR and the 
𝑇1 native values 𝑇10. 
For the implementation of this method, the first step was to differentiate 
between the baseline signal from the one acquired after contrast injection. A ROI was 
plotted in an artery, usually the abdominal aorta, with in-plane flow and the signal 
intensity variation over time was used to identify the baseline more accurately. Selecting 
a pixel (figure 3.9a) it is possible from its signal temporal variation plot (figure 3.9b) to 
identify, for this patient, 3 points belonging to the baseline. 
 
Figure 3.9: a) Anatomical location of the chosen pixel in the artery region. b) Temporal variation of the signal over 
time (arbitrary units). Identification of a baseline of 3, starting the acquisition at time 4. 
 
The baseline had to be identified for each patient, and for pre- and post-
treatment data, since the baseline length varied from patient to patient and even within 
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patient. The signal intensity 𝑆(0) in equation 3.18 was determined, for each pixel, from 
the average signal intensity of the baseline. 
Having determined the baseline signal 𝑆(0), the signal variation over time 𝑆(𝑡), 
the native 𝑇1 values, and knowing the relaxivity of the contrast agent and the acquisition 
parameters 𝑇𝑅 and 𝜃, it is possible to apply 3.18 to convert signal intensity variation to 
CA concentration variation. 
 
3.3.4 Perfusion Parameters 
After the signal to contrast agent concentration conversion has been made, the 
same procedure is applied for the portal vein and hepatic artery ROIs. Both 𝑇1 and 
concentration determination for these structures were performed in a pixel-by-pixel 
basis. Although for the kinetic parameters simulation, according to the model, each pixel 
within the liver ROI is defined by a set of parameters that is used to perform the non-
linear fit. For each pixel there is the contrast agent concentration curve of that position, 
and single hepatic artery and portal vein curves. Both hepatic artery and portal vein 
concentration curves were obtained by averaging the values within the region of the 
respective ROIs. In other words, the concentration of either one of the vessels, for a 
temporal instant, is represented by a single average value that is the same for any pixel 
of the liver in the same temporal instant.  
At this point, having determined the liver concentration maps, and the portal vein 
and hepatic artery input functions, it is possible to apply the dual-input one-compartment 
model equation 3.1 to extract the physiological kinetic constants 𝑘1𝑎, 𝑘1𝑝 and 𝑘2 to 
former conversation into perfusion parameters. 
Solving the equation 3.1 for 𝐶𝐿(𝑡) and taking into account the transit time from 
the hepatic artery and portal vein to the liver by adding the τ𝑎 and τ𝑝delay parameters, 
the concentration of contrast agent over time is  
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𝐶𝐿(𝑡) =  ∫ [
𝑡
0
𝑘1𝑎𝐶𝑎(𝑡
′ − τ𝑎 ) + 𝑘1𝑝𝐶𝑝(𝑡
′ − τ𝑝)]𝑒
−𝑘2(𝑡−𝑡
′)𝑑𝑡′ 
3.19 
Where 𝑡′ represents a dummy integration variable and 𝐶𝐿(0) = 0. Knowing the 
temporal variation of contrast agent concentration in the liver and in both the hepatic 
artery and the portal vein, it is possible to calculate, the unknown kinetic parameters 
𝑘1𝑎, 𝑘1𝑝 and 𝑘2, using a non-linear fitting algorithm. 
Because the mean transit times from the aorta and portal vein regions to the 
liver ROI, respectively represented by the delay parameters τ𝑎 and τ𝑝 vary depending 
on the patient and how its concrete measurement was performed during acquisition, 
was assigned a value of 3 seconds for both [30]. 
The Levenberg-Marquart was the chosen method for the non-linear fit of the 
kinetic parameters to the data by the equation 3.20. This method is suitable to use when 
fitting a parameterized function to a set of measured data points by minimizing the sum 
of the squares of the errors between the data points and the function, where there is a 
non-linear dependence on the unknown parameters [31].  
The implementation of this method comprises an iterative procedure where the 
values of the unknowns (in our case the kinetic constants) are adjusted in order to 
minimize the sum of the squares of the errors between the values predicted by the 
model and the measured data. 
 
3.3.5 Implementation in Matlab 
Matlab scripts were created to implement each step of the algorithm. 
For the determination of the 𝑇1 values, the software proceeds as follows: 
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1. Starts a cycle that reads the dicom images corresponding to all the flip angles and 
stores the values in a multidimensional array of size 𝑛𝑥 × 𝑛𝑦 × 𝑧, where 𝑛𝑥 and 
𝑛𝑦 correspond to the number of pixels in the vertical and horizontal directions, 
and 𝑧 stands for the number of flip angles. 
2. Extracts 𝑇𝑅 and flip angle values from the dicom header and creates a flip angle 
vector ([𝜃1 𝜃2 𝜃3… 𝜃𝑍]) were each theta corresponds to the specific value of 
the flip angle. 
3. Runs a double cycle that goes through all 𝑛𝑥 and 𝑛𝑦 indexes and for each pixel 
extracts the signal values of each flip angle acquisition and stores into a vector 
([𝑆1 𝑆2 𝑆3… 𝑆𝑍])  of the same size of the flip angle. With the 𝑇𝑅, flip angle and 
signal vectors uses the polyfit function, in order to find the coefficients of the 
polynomial 𝑃(𝑋) of degree 1 that best fits equation 3.7 in a least-squares sense 
and on a pixel-by-pixel basis. 
4. Repeats of the previous process to all the slices, to obtain 20 dicom images 
containing the parametric maps of the native 𝑇1 values of the tissues. 
After 𝑇1 mapping being completed, in order to achieve the CA concentration, 
the script goes through the following steps: 
1. Receives the directories of 𝑆(0), 𝑆(𝑡) and 𝑇1 and imports its values to the 
workspace. 
2. Uses the dicom header of the dynamic scans to extract 𝑇𝑅 and 𝜃 parameters. 
5. Based on the number of dynamic scans, creates a multidimensional array of size 
𝑛𝑥 × 𝑛𝑦 × 𝑁 where 𝑛𝑥 and 𝑛𝑦 correspond to the number of pixels in the 
vertical and horizontal directions and 𝑁 stands for the number of dynamics. 
3. Initiates a cycle that goes through all 𝑛𝑥 and 𝑛𝑦 indexes of the array and for each 
position extracts the value from 𝑆(0), 𝑆(𝑡) and 𝑇1 for that position. 𝑆(𝑡) is here 
a vector of size 1 × 1 × 𝑁 containing all values of signal intensity for that specific 
pixel. Applies the 3.18 formula to these values and repeats the process for all 
image indexes and sets the concentration values, obtained also as vector, in the 
multidimensional array position (𝑥𝑖, 𝑦𝑖). 
4. Repeats the process to all slices. 
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The resulting output consists of a multidimensional array (figure 3.10) where each 
2D array corresponds to a map of contrast agent concentration at a given time. 
 
Figure 3.10: Example (with non-real values) of the type of structure obtained in the calculation of concentration. 
Choosing a pixel of coordinates (X,Y), it is possible to access the values of concentration over time (represented by 
the third dimension). Adapted from [36]. 
 
The previous steps were applied to pixels within the liver ROI but, in order to 
determine the kinetic constants referred to in equation 3.19, 𝑇1 and contrast agent 
concentration of the hepatic artery and portal vein had to be determined. 𝑇1 calculation 
was performed pixel-by-pixel at the defined ROIs for the blood vessels, but only a single 
value was considered, corresponding to an average of the 𝑇1 values inside the region. 
Only values between 900-2000 milliseconds were accepted and in cases where the 
average values were outside the range, 𝑇1 was artificially set in 1584 milliseconds for 
the portal vein and 1664 milliseconds for the hepatic artery, values estimated for the 
longitudinal relaxation of blood at 3T [32].  Same procedure was made for the contrast 
agent concentration determination at the blood vessels, where only one value for each 
instant of the dynamic study was determined, corresponding to the average values for 
the concentration at the hepatic artery and portal vein ROIs. 
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Having determined the concentration of the contrast agent in all structures 
comprised in the model, it is possible to simulate the kinetic constants and calculate the 
perfusion parameters.  
The implemented method for the perfusion parameters determination goes 
through the following steps: 
1. Receives the directories of 𝐶𝐿, 𝐶𝑎 and 𝐶𝑝 and imports its values to the 
workspace. 
2. Uses the dicom header of the dynamic scans to create a vector of times, 
correspondent to the real acquisition times. 
3. Creates an objective-function from equation 3.19 to simulate the liver contrast 
agent concentration, implemented by the cumtrapz function that computes an 
approximation of the cumulative integral of 𝐶𝐿(𝑡) via the trapezoidal method. 
4. Loads the liver ROIs to the workspace as masks to limit the number of pixels 
used in the computations of the next step. 
5. Initiates a cycle that goes through all 𝑛𝑥 and 𝑛𝑦 indexes of the liver concentration 
multidimensional array (being 𝑛𝑥, 𝑛𝑦, and 𝑁, the number of pixels in the vertical 
and horizontal directions, and the number of dynamics, respectively). For each 
index correspondent to the liver mask, gets 𝐶𝐿(𝑡), 𝐶𝑎(𝑡), and 𝐶𝑝(𝑡) values as 
vectors of size 1 × 1 × 𝑁 containing all temporal values of contrast agent 
concentration for that specific pixel. Applies the Levenberg-Marquardt algorithm 
through the lsqnonlin Matlab fitting function to the objective-function iterates until 
the sum of the squares of errors between the parameterized objective-function 
and the experimental curve obtained for 𝐶𝐿 is minimized with a maximum of 800 
iterations. 
6. From the fitted curve 𝐶𝐿(𝑡) derives the set of kinetic constants used in the 
equations 3.2, 3.3 and 3.4 to determine the perfusion parameters 𝑃𝑎 , 𝑃𝑝and 𝑃𝐿 
with the extraction fraction equal to 1. 
7. Repeats the process for all indexes and set the determined values in four 
parametric maps that are converted to dicom images. 
8. Repeats the process to all slices. 
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Chapter 4  
Results 
4.1 Signal Enhancement and and tumor identification 
Figure 4.1 presents a typical example of coronal abdominal slice acquired during 
the dynamic study. The data belongs to Patient 3 and was acquired during the post-
treatment examination. This example illustrates the expected signal enhancement after 
contrast injection at different time points. 
Figure 4.1a was acquired before contrast injection and it shows the baseline signal 
from tissues. A few seconds after CA injection (figure 4.1b), there is signal enhancement 
at the bottom of the right liver lobe, indicating the tumor location. In addition, regions 
such as the heart or arteries also shown signal enhancement. Figure 4.1c represents the 
signal from the last dynamic that was acquired for the same slice. It shows contrast wash-
out in the tumor while healthy liver parenchyma still shown signal enhancement.  
 
Figure 4.1: Contrast-enhancement in a liver MR slice from post-treatment acquisition of patient 3: a) pre-contrast; 
b) “early” contrast-enhancement; c) “late” contrast-enhancement. 
Signal enhancement of the liver parenchyma is lower compared to the 
enhancement of the hypervascularized area, where there is higher concentration of 
contrast between the plasma and the tumor region. These results are expected as tumor 
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has an earlier enhancement as it is mainly fed by arteries, while the blood input of the 
normal parenchyma is from the portal vein. From figure 4.1b, a representative pixel from 
both tumor and healthy parenchyma regions were chosen and their variation of the 
signal intensities over time was plotted (figure 4.2) in order to see enhancement 
differences. 
 
Figure 4.2: Typical enhancement signal curves (of arbitrary units) derived from pixels in the tumor and healthy 
parenchyma regions respectively. 
From figure 4.2 it is possible to notice the existence of an enhancement peak, 
correspondent to the signal from early dynamics of the tumor location with progressive 
washout over time. For the pixel from the healthy parenchyma it is possible to see that 
there is also latter signal enhancement with smaller magnitude, when compared to the 
one from the tumor. The latter and smaller enhancement from parenchyma ROIs and 
the early raising in signal enhancement from tumor ROIs are characteristic behaviors 
from both regions. 
In this way, the identification of the tumor region and boundaries from the first 
3 dynamic after contrast injection is, in general, quite straightforward. Images from the 
last dynamics are not suitable as they show the late contrast-enhancement of normal 
liver parenchyma while the tumor is already in the wash-out phase. As a consequence, 
the identification of the tumor is less obvious in these dynamics. 
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4.2 ROIs definition  
ROIs for liver, tumor, abdominal aorta and portal vein were defined in ImageJ. 
This tool was used instead of Matlab as it enables importation of all slices of each dynamic 
in a single stack, allowing very simple manipulation of the image brightness, contrast, 
color maps, drawing tools, among others functions. Given that ROIs from ImageJ were 
obtained in the .roi extension, a function to import the defined ROIs to the Matlab 
workspace was created. It transformed the defined ROI into a .mat file with values of 
0’s and 1’s, masking the pixels within the ROI into values of 1.  
The figures below show the ROIs for the liver (yellow) and for the tumor 
(magenta), corresponding with each patient. For each patient two sets of ROIs, 
corresponding with the acquisitions from pre- and post-treatment. Ideally, the same ROI 
for pre- and post-treatment analysis should be used. However, this approach could not 
be taken because the FOV in pre- and post-treatment acquisitions was often not 
positioned in exactly the same place. As a consequence, this led to changes in the 
position and orientation of the liver. Furthermore, the anatomy surrounding the tumor 
was often changed from pre- to post-treatment, which further complicated the process. 
In order to overcome this difficulty, the ROIs of pre- post-treatment were selected so 
that they would be positioned in approximately the same anatomical region. 
 
Figure 4.3: Liver (yellow) and tumor (magenta) ROIs of Patient 1 in: a) pre-treatment and b) post-treatment scans. 
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Figure 4.4: Liver (yellow) and tumor (magenta) ROIs of Patient 2 in: a) pre-treatment and b) post-treatment scans. 
 
 
Figure 4.5: Liver (yellow) and tumor (magenta) ROIs of Patient 3 in: a) pre-treatment and b) post-treatment scans. 
 
 
Figure 4.6: Liver (yellow) and tumor (magenta) ROIs of Patient 4 in: a) pre-treatment and b) post-treatment scans. 
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Figure 4.7: Liver (yellow) and tumor (magenta) ROIs of Patient 5 in: a) pre-treatment and b) post-treatment scans. 
 
It is important to refer that in order to more accurately segment the tumor, 
which is often irregular and distributed amongst different slices, the defined ROIs are 
three dimensional, therefore defined with more than one slice. 
 
4.3 𝑻𝟏 parametric maps  
𝑇1 parametric maps (PM) were obtained for all slices of every patient using the 
variable flip angle approach. Figures. 4.8-4.12 show the 𝑇1 PM of one slice per patient, 
the one where the tumor is more visible. 𝑇1 values are shown in milliseconds for pre-
treatment (left) and post-treatment (right). 
 
Figure 4.8: 𝑻𝟏 parametric maps for Patient 1. 
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Figure 4.9: 𝑻𝟏 parametric maps for Patient 2. 
 
Figure 4.10: 𝑻𝟏 parametric maps for Patient 3. 
 
Figure 4.11: 𝑻𝟏 parametric maps for Patient 4. 
 
Figure 4.12: 𝑻𝟏 parametric maps for Patient 5. 
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Results demonstrate that, for all subjects, the highest 𝑇1 values are obtained in 
blood vessels and tumor regions. For example, for Patient 5 (figure 4.12) in pre-
treatment (left), values in the range of 1500 –  1800 𝑚𝑠 are positioned in the left lobe, 
which was previously defined as the tumor zone. As there is an increased inflow of 
arterial blood to the tumor zone, it is expected for these structures to have 𝑇1 values 
from approximately 1500 to 1700 𝑚𝑠, which correspond to the values of longitudinal 
relaxation of blood in a magnetic field intensity of 3T. In the same figure, the central part 
of the liver presents 𝑇1 values between 600 − 800 𝑚𝑠, which are characteristic values 
for hepatic parenchyma with normal perfusion. Apart from the area identified as a tumor, 
it is also possible to observe a region located in the right lobe, which also shows high 
values of 𝑇1, similar to those found in tumor. In the post-treatment 𝑇1 map of the same 
patient, an overall increase of 𝑇1 values can be seen, possibly suggesting tumor growth.  
Another illustrative case is that of Patient 4, which is presented in figure 4.11. 
Here, the regional decrease in 𝑇1 values on post-treatment could suggest tumor 
regression. However, this result goes against what was shown in figure 4.6b, where there 
is a larger hepatic area of signal enhancement in post-treatment, thus suggesting the 
opposite, namely, tumor increase. This can be justified by the slice that was used to show 
the 𝑇1 map. Choosing another representative slice of the liver for the same patient in 
post-treatment (figure 4.13), it is observed that there is an increase of the area with high 
values of 𝑇1. 
 
Figure 4.13: 𝑻𝟏 map of an alternative slice of Patient 4 in post-treatment examination that shows a larger 
area of the liver with high 𝑻𝟏 values. 
For the remaining patients, a similar behavior of the spatial distribution of 𝑇1 
values was observed, i.e. highest values of 𝑇1 corresponding with either tumor, largely 
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irrigated areas or blood vessels. The exception holds for Patient 1 (fig. 4.8) where there 
is a general increase of 𝑇1 values from pre- to post-treatment maps. 
4.3 Contrast Agent Concentration 
It is possible to describe the evolution of CA concentration in tissues by 
converting the MR signal into concentration units (𝑚𝑀/𝐿). Contrast agent 
concentration, an intermediate step in the algorithm to calculate kinetic parameters, was 
stored in a multidimensional array. Thus, for each slice there is a 𝑛𝑥 × 𝑛𝑦 × 𝑁 array 
where the concentration values for each dynamic can be represented as a 2D 128 ×
128 matrix of doubles. By storing the CA concentration in a multi-dimensional array, it 
is possible to plot CA concentration-time curves on a pixel-by-pixel basis, by choosing 
pixels from desired regions. This procedure is illustrated in figure 4.14. 
 
Figure 4.14: a) to c) - Identification of the abdominal aorta), portal vein and small segments from tumor and 
parenchyma ROIs from post-treatment dynamics of Patient 3. d) Average CA concentration-time curves from the 
displayed ROIs. 
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The tumor shows a rapid increase in CA concentration, when compared to the 
behavior of healthy parenchyma, followed by a quick washout, which reflects the fact 
that the tumor is a highly irrigated region. 
Furthermore, the abdominal aorta and the portal vein concentration-time curves 
show the expected relative peak time delay, i.e. the peak of CA concentration is reached 
first in the artery and then in the portal vein. As expected, there is a rapid and greater 
accumulation of contrast in the tumor ROI compared to the parenchyma. This is a result 
of the increased local arterial blood feeding the tumor when compared to the healthy 
parenchyma, where a main portal vein blood feeding is expected. 
Similar concentration curves were obtained for the other patients using other 
sets of pixels. The concentration curves in each pixel were used to calculate the kinetic 
parameters using a non-linear fitting procedure. 
 
4.4 Perfusion Parameters  
Figures 4.15 – 4.19 show the kinetic parametric maps obtained before and after 
treatment for all patients, considering the dual-input one-compartment model. It was 
chosen to present as final results the kinetic constants (𝑘1𝑎, 𝑘1𝑝, 𝑘2) and the overall liver 
perfusion (PL), calculated according to equation 3.4. The kinetic parameters are 
presented in units of 𝑠−1 as well as the liver perfusion. The extraction fraction of the 
contrast agent in the liver, 𝐸 has no units and in this work it was assumed to be 1 for all 
cases. In order to present the results in DICOM images, it was necessary to apply a 
scaling factor of 104 to all values, so that real values can be obtained from the integers 
stored in DICOM format, divided by the scaling factor. 
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Figure 4.15: 𝒌𝟏𝒂, 𝒌𝟏𝒑, 𝒌𝟐 and PL parametric maps for Patient 1. 
 
Figure 4.16: 𝒌𝟏𝒂, 𝒌𝟏𝒑, 𝒌𝟐 and PL parametric maps for Patient 2. 
 
Figure 4.17: 𝒌𝟏𝒂, 𝒌𝟏𝒑, 𝒌𝟐 and PL parametric maps for Patient 3. 
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Figure 4.18: 𝒌𝟏𝒂, 𝒌𝟏𝒑, 𝒌𝟐 and PL parametric maps for Patient 4. 
 
Figure 4.19: 𝒌𝟏𝒂, 𝒌𝟏𝒑, 𝒌𝟐 and PL parametric maps for Patient 5. 
The success treatment of patients may be assessed qualitatively by comparing the 
perfusion status before and after treatment. According to the proposed model, it is 
possible to classify patients into categories of treatment responders and non-responders. 
Response to treatment implies an overall decrease in perfusion in the post-treatment PL 
parametric maps, which was found in Patient 1 and Patient 3. Patients 2, 4 and 5 are 
accordingly to this model non-responders since there is an increase in the overall 
perfusion after treatment. 
Even through visualization of the images of early signal enhancement, tumor 
boundaries were not easy to define for Patient 1. In the signal intensity images, no 
localized signal enhancement occurs, in fact, dispersion of high values of intensity are 
observed among the entire region of left lobe and in the upper zone of the right lobe. 
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Using the same ROI and analyzing the parametric maps from the same slice before and 
after treatment, there is a significant decrease in all kinetic parameters and consequently 
in the global perfusion. It is important to refer that pre-treatment maps present a range 
of values 8 times superior that the post-treatment ones.  
𝑘1𝑎 and 𝑘1𝑝 maps of Patient 2 after treatment show increased values when 
compared to the same parameters before treatment, resulting in an overall increase in 
liver perfusion. Increased values of perfusion on the liver outer edges may suggest new 
vessels recruitment and consequently tumor growth despite treatment. Although this 
effect may also be artifactual. It is noticed that there are many areas of the liver where 
perfusion is zero. Furthermore, 𝑘2 maps present higher values than 𝑘1𝑎 and 𝑘1𝑝 for this 
patient, suggesting high rates of contrast agent extraction from the liver by the hepatic 
vein.   
Besides the defined ROI of the tumor for Patient 3, it is possible to identify, in 
figure 4.17, other tumoral masses in the upper region of the liver, which also have 
increased kinetic constants and overall perfusion. From the comparison of the color 
maps before and after treatment it becomes evident that there is an overall decrease of 
the liver perfusion after 3 months of treatment. An interesting observation in this patient 
is the existence of an area within the defined ROI for the tumor, where all parameters 
are zero. The absence of blood perfusion in this region may suggest the presence of a 
necrotic area. Comparing 𝑘1𝑎 and 𝑘1𝑝 maps before treatment, it is possible to find 
alterations of the vascular supply of the liver. Here the blood supply to the tumor is 
mainly arterial. However, from the observation of the post-treatment maps, seems to 
be a reestablishment of the blood supply, expected to be mainly from the portal vein, by 
the decrease in 𝑘1𝑎 values and increase in the 𝑘1𝑝 ones.  
From the parametric maps of Patient 4, in figure 4.18, it is possible to see 
augmented liver perfusion after treatment. In both pre- and post-treatment maps, the 
contribution of global liver perfusion seems to be mainly arterial since the values of 𝑘1𝑎 
rate constant are relatively higher than 𝑘1𝑝 ones. Besides the increase of the perfusion, 
there is tumor migration to an upper region from its previous location. 
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Parametric maps of the Patient 5, illustrated in figure 4.19 show a marked 
increased liver perfusion after treatment. Apart from the highest values of perfusion 
being found within the ROI defined for the tumor, it is possible to see increased blood 
perfusion also for the hepatic parenchyma surrounding the tumor. This may represent 
the process of recruitment of more vessels to the tumor region, supplied by the hepatic 
artery through neoarteriogenesis process. In fact, there is almost no blood supply 
contribution from the portal vein to the tumor. It is possible to see that there are high 
values of 𝑘1𝑝 in few points within the tumor, being mainly zero for the rest of the liver. 
Within the tumor of the post-treatment parametric maps, it is possible to see a small 
area with absence of perfusion, suggesting development of necrotic tissue. 
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Chapter 5  
Discussion 
The main goal of the present work was the implementation of a software for 
perfusion quantification in liver that better reflected the real liver blood supply. A dual 
input one-compartment model was considered, comprising both venous and arterial 
blood contributions to the liver. Using this mathematical model it was possible to 
determine the temporal evolution of the contrast agent concentration and calculate the 
kinetic parameters that described the transport of the contrast agent from the portal 
vein and hepatic artery to the liver. 
For that purpose, an algorithm composed by a series of distinct steps was 
implemented. The software implementation was not a trivial procedure as it involved 
the manipulation of complex numeric methods, handling several variables and non-linear 
equations. Several strategies were adopted during the implementing procedure, in order 
to keep model integrity and to obtain a software with suitable clinical applicability.  
One of the adopted strategies was the minimization of the total computation 
time with a view on clinical application. As already mentioned, the number of pixels that 
were used in the calculations was limited only to the structures of interest. For that 
purpose, ROIs limited to the liver and few adjacent structures were defined. This 
procedure was particularly important for the calculation of the native 𝑇1 values as well 
as that of the kinetic parameters, since these operations involve non-linear fitting 
procedures, which have long computation times. With the application of ROIs, the 
computation time decreased considerably (from approximately two hours to twenty 
minutes per patient, for the kinetic parameters determination procedure). Some 
difficulties were found in the identification of anatomical structures, especially in the case 
of tumor, portal vein and liver edge. The liver is a large organ and is therefore susceptible 
to motion artifacts and partial volume effects, hence making the identification of liver 
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boundaries sometimes hard. Furthermore, tumors are irregular structures that vary 
their position depending on the imaging slice. For that reason, tumor ROIs were defined 
not only based on a single slice, but considering other slices that included parts of the 
same tumor, i.e., 3-dimentional ROIs. The portal vein was the most difficult structure to 
identify because of its size and because sometimes it was positioned in an oblique plane 
to the acquisition plane. 
Another assumption consisted on the arterial input function measurement in the 
abdominal aorta, instead of measuring it on the hepatic artery. The proposed model 
required the definition of both an arterial and venous input functions. There were no 
problems in detecting the venous function, which was acquired over the portal vein ROI. 
However the arterial input function definition, which ideally would be acquired over the 
hepatic artery, was more difficult. The identification of this structure was practically 
impossible due to its reduced size and position within the FOV, so a ROI over the 
abdominal aorta was placed, assuming that both arteries had the same signal and 
consequently the same contrast agent concentration. 
The removal of outliers was one of the strategies that was used to keep model 
integrity and avoid the propagation of numerical instabilities. Depending on the 
orientation of the portal vein and abdominal aorta with respect to the FOV, it could be 
that the flow in these vessels was not completely in-plane. As a consequence, inflow 
effects originated native 𝑇1 values outside the expected range of values for the 
longitudinal relaxation of blood at 3T. This represented a potential source of error to 
the contrast agent concentration curves of the blood vessels. In order to minimize this 
effect, it was chosen to attribute 𝑇1 values from literature to those pixels that were 
affected by inflow effects. It was also necessary to remove outlier values when calculating 
the contrast agent concentration for the liver. In this procedure it was noticed the 
presence of negative values of concentration. Spatial localization of these pixels 
suggested that they were either from noisy regions or from regions with no contrast 
enhancement and it was chosen to set the contrast agent concentration values of these 
pixels artificially to 0. The justification for these outlier values reflects one of the major 
limitations of this work, in which all model equations were equally applied to every pixel, 
regardless of whether there was signal enhancement from contrast agent arrival or not. 
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Pixels that violated the model assumption of enhancement affected the final results and 
were a confounding factor in the interpretation of kinetic parametric maps. For that 
reason, they had to be signaled as outliers. 
One important point consisted in the assignment of values to parameters of the 
model equations, which were unknown or for which no measurements were made. The 
values of the mean transit time of the contrast agent from hepatic artery and portal vein 
to the liver were considered to be, for both parameters, equal to 3 seconds. This value 
was taken from literature, and it is not considered a potential source of error, as it is 
nearly half of the temporal resolution that was used in the acquisition of the data. In this 
situation, the transport of the contrast agent from the abdominal aorta and portal vein 
to the liver can be considered to be instantaneous. Ideally, the correct assessment of 
the perfusion parameters also takes into account the influence of the small vessel 
hematocrit and the correct measurement of the extraction fraction of the contrast agent 
in the liver, which did not occur. The hematocrit measurement represents an invasive 
procedure that could not be performed for all patients, and for the calculations, its 
influence was discarded. Due to due the lack of extraction fraction measurement, it was 
considered to be 1, as this value is referenced by literature to be used in situations 
where the contrast agent has free access to the extravascular space. These two last 
assumptions may have caused an underestimation of the rate constants and consequently 
of the overall liver perfusion. 
The validation of the software using a clinical population with HCC allowed to 
highlight the positive aspects of the dual-input one-compartment model analysis of the 
data over the traditionally used model. The parametric maps, show many differences 
between 𝑘1𝑎 and 𝑘1𝑝 constants, which proves distinct contributions for the overall liver 
perfusion from arterial and venous input. This is a very important issue when considering 
the Tofts model that only assesses perfusion through the determination of the 𝐾𝑡𝑟𝑎𝑛𝑠 
and considering a single input. Liver perfusion that previously was determined only by 
transendothelial transport of the contrast agent into de extravascular-extracellular space 
from a single vascular input function, now contemplates two distinct vascular inputs. It 
is possible to study with more accuracy and more detail, if there are different 
contributions from either one of the vascular inputs to the perfusion and quantify them. 
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From the parametric maps, not only was it possible to point differences in the 
venous and arterial contributions to the liver perfusion, but also to see that the model 
was susceptible to detect variations of perfusion after treatment. It was possible establish 
a classification of treatment responsive (Patients 1 and 3) and non-treatment responsive 
for patients (Patients 2, 4 and 5), based on, respectively, the decrease and increase of 
the global liver perfusion after three months of treatment. An interesting result was the 
ability to detect an increased venous perfusion in one of the responsive patients (Patient 
3). As the blood perfusion to the tumor is considered to be mainly arterial, in the case 
of this patient there is a reestablishment of the blood supply from the portal vein 
followed by a decrease in the arterial one, stating that treatment was effective in the 
decrease of the tumor blood perfusion. 
Values of 𝐾𝑡𝑟𝑎𝑛𝑠 from Tofts model were found in the literature for many types 
of tumors with different sizes, staging and aggressiveness. Taking for example a particular 
study [32] values of 0,11  and 0,10 𝑠−1 were found for 𝐾𝑡𝑟𝑎𝑛𝑠 respectively in a liver 
hemangioma and metastases, using a CE MRI study. A more similar case, in patients with 
HCC [8], values in the range of 0,75 − 0,90 𝑠−1 for 𝐾𝑡𝑟𝑎𝑛𝑠 were found in the tumor 
ROI. The interpretation of 𝐾𝑡𝑟𝑎𝑛𝑠 is dependent on the tissue involved and on the 
underlying physiological circumstances, although it is possible to see that the same 
orders of magnitude are found in 𝑘1𝑎 and 𝑘1𝑝 values for the patients of the present 
study.  An interesting follow-up of this study would be to perfusion results for each 
patients, obtained using both the Tofts model and the proposed model using a histogram 
analysis in order to quantify tumors’ heterogeneity. 
In general, it is possible to say that the application of the dual input single-
compartment model to clinical data yielded encouraging results and showed the 
advantages of using mathematical models that better describe the vasculature of the liver 
to analyze perfusion data. Nevertheless, this study contains some weaknesses that 
should be improved in the future: 
1 - Intra- and inter-subject variability of the acquisition parameters. The latter 
were not exactly reproduced from subject to subject and within the same patient, also 
sometimes not exactly reproduced from pre- to post-treatment acquisitions. This led to 
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different acquisition geometries that made it impossible to use e.g. the same ROIs in pre- 
and post-treatment analysis. The applied treatment and the disease evolution also 
induced anatomical changes, particularly to the tumor morphology, also requiring new 
ROIs definition. 
 2 - Artifacts due to respiratory motion caused signal dropout that made the 
identification of structures of interest difficult and invalidated many pixels to be suitable 
for the application of the model equations because of low SNR. 
3 - Limited number of patients used for the software testing.  The database, from 
where data presented in this project was extracted, included more MRI data of patients 
with hepatocellular carcinoma following the same protocol. However, for many of them, 
main structures of interest, like portal vein and abdominal aorta, were not included in 
the imaged slices, making it impossible to apply the dual-input single compartment model 
to this patients.  
Limitations of the study precluded the application of this approach to a larger 
sample of clinical data. Nevertheless, software implementation has been successfully 
accomplished and producing treatment sensitive perfusion results. 
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Chapter 6  
Conclusion 
Liver hemodynamics is a main determinant of hepatic function. The assessment 
of liver perfusion remains controversial regarding the variable model-based approaches 
than can be used.   
This work represents a “proof of concept”, i.e. the main objective of this thesis 
was not to create a perfect algorithm of perfusion parameters calculation, but to 
demonstrate that it was possible to perform the implementation of a model with 
assumptions that better describe the liver vascular system, when compared to the 
traditional Tofts model. A more accurate perfusion assessment through models that 
better reflect the real vascular architecture of the liver, may help to characterize and 
predict the onset of malignancies as well as to study the effectiveness of therapies. The 
implemented software was tested in a particular clinical case of limited data from patients 
with hepatocellular carcinoma, however patients with other liver perfusion diseases 
could have been used for the same purpose.  
Future work may focus on the clinical validation of the developed software. 
Strategies involve the development of a complete user interface for the software in 
order to extend perfusion quantification in the liver to clinical routine. Tests with more 
patients will allow longitudinal studies and statistical inference. Furthermore, standard 
operating procedures with specific set of pulse sequence parameters should to be 
established.  
  
  
 
Chapter 6 – Conclusion   64 
 
 
 
References   65 
 
 
References 
[1] P. S. Tofts and a G. Kermode, “Measurement of the blood-brain barrier 
permeability and leakage space using dynamic MR imaging. 1. Fundamental 
concepts.,” Magn. Reson. Med., vol. 17, no. 2, pp. 357–67, Feb. 1991. 
[2] V. D. Wynsberghe, C. R. Noback, and C. Robert, Human Anatomy and Physiology, 
3rd edition. New York, NY: McGraw-Hill, Inc, 1995, p. 872. 
[3] S. K. Saladin, Anatomy and Physiology. The Unity of Form and Function., Second 
Edition. New York: McGraw-Hill Companies Inc., 2001. 
[4] V. Mitra and J. Metcalf, “Functional anatomy and blood supply of the liver,” 
Anaesth. Intensive Care Med., vol. 13, no. 2, pp. 52–53, Feb. 2012. 
[5] C. H. Thng, “Perfusion magnetic resonance imaging of the liver,” World J. 
Gastroenterol., vol. 16, no. 13, p. 1598, 2010. 
[6] F. A. Longo Dan, Harrison’s Gastroenterology and Hepatology, 18th ed. McGraw Hill 
Professional, 2010, p. 752. 
[7] P. V Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee, “Perfusion imaging 
of the liver: current challenges and future goals.,” Radiology, vol. 234, no. 3, pp. 
661–73, Mar. 2005.  
[8] M. a Haider, F. a Farhadi, and L. Milot, “Hepatic perfusion imaging: concepts and 
application.,” Magn. Reson. Imaging Clin. N. Am., vol. 18, no. 3, pp. 465–75, Aug. 
2010. 
[9] F. X. Bosch, J. Ribes, M. Díaz, and R. Cléries, “Primary liver cancer: Worldwide 
incidence and trends,” Gastroenterology, vol. 127, no. 5, pp. S5–S16, Nov. 2004. 
[10] A. P. Venook, C. Papandreou, J. Furuse, and L. L. de Guevara, “The incidence and 
epidemiology of hepatocellular carcinoma: a global and regional perspective.,” 
Oncologist, vol. 15 Suppl 4, pp. 5–13, Jan. 2010. 
[11] C. L. Tinkle and D. Haas-Kogan, “Hepatocellular carcinoma: natural history, 
current management, and emerging tools.,” Biologics, vol. 6, pp. 207–19, Jan. 2012. 
[12] B. R. Greenberger N., Blumberg R., Current Diagnosis and Treatment: 
Gastroentrology, Hepatology and Endoscopy. New York, NY: McGraw-Hill 
Companies, 2009, p. 580. 
[13] T. Harrison, Harrison Medicina Interna, 11a ed. Rio de Janeiro RJ: Editora 
Guanabara, 1988, p. volume 2. 
References   66 
 
 
[14] M. J. Sands and A. Levitin, “Basics of magnetic resonance imaging,” Semin. Vasc. 
Surg., vol. 17, no. 2, pp. 66–82, Jun. 2004. 
[15] Haacke Mark, Brown Robert, Thompson Michael, and Venkatesan Ramesh. 
Magnetic Resonance Imaging, physical principles and sequence design. Wiley-Liss, 
1999. 
[16] R. M. Van Geuns, P. A. Wielopolski, H. G. De Bruin, B. J. Rensing, P. M. A. Van 
Ooijen, M. Hulshoff, M. Oudkerk, and P. J. De Feyter, “Resonance Imaging,” vol. 
42, no. 2, pp. 149–156, 1999. 
[17] C. J. Aine, “A conceptual overview and critique of functional neuroimaging 
techniques in humans: I. MRI/FMRI and PET.,” Crit. Rev. Neurobiol., vol. 9, no. 2–3, 
pp. 229–309, Jan. 1995. 
[18] D. S. MacDonald-Jankowski, “Magnetic Resonance Imaging. Part 1: the Basic 
Principles,” Asian J. Oral Maxillofac. Surg., vol. 18, no. 3, pp. 165–171, Sep. 2006. 
[19] T. Karamitsos and S. Neubauer, “Cardiovascular magnetic resonance imaging,” 
Medicine (Baltimore)., vol. 42, no. 8, pp. 461–467, Aug. 2014. 
[20] M. O. Leach, K. M. Brindle, J. L. Evelhoch, J. R. Griffiths, M. R. Horsman, a Jackson, 
G. C. Jayson, I. R. Judson, M. V Knopp, R. J. Maxwell, D. McIntyre, a R. Padhani, P. 
Price, R. Rathbone, G. J. Rustin, P. S. Tofts, G. M. Tozer, W. Vennart, J. C. 
Waterton, S. R. Williams, and P. Workman, “The assessment of antiangiogenic 
and antivascular therapies in early-stage clinical trials using magnetic resonance 
imaging: issues and recommendations.,” Br. J. Cancer, vol. 92, no. 9, pp. 1599–610, 
May 2005. 
[21] P. S. Tofts, “Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.,” J. Magn. 
Reson. Imaging, vol. 7, no. 1, pp. 91–101. 
[22] P. S. Tofts, “Optimal detection of blood-brain barrier defects with Gd-DTPA MRI-
the influences of delayed imaging and optimised repetition time.,” Magn. Reson. 
Imaging, vol. 14, no. 4, pp. 373–80, Jan. 1996.  
[23] R. Materne, B. E. Van Beers, M. Smith, I. Leconte, J. Jamart, J. P. Dehoux, a Keyeux, 
and Y. Horsmans, “Non-invasive quantification of liver perfusion with dynamic 
computed tomography and a dual-input one-compartmental model.,” Clin. Sci. 
(Lond)., vol. 99, no. 6, pp. 517–25, Dec. 2000. 
[24] J. M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.-F. Blanc, A. C. de 
Oliveira, A. Santoro, J.-L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. 
Bolondi, T. F. Greten, P. R. Galle, J.-F. Seitz, I. Borbath, D. Häussinger, T. 
Giannaris, M. Shan, M. Moscovici, D. Voliotis, and J. Bruix, “Sorafenib in advanced 
hepatocellular carcinoma.,” N. Engl. J. Med., vol. 359, no. 4, pp. 378–90, Jul. 2008. 
[25] J. Buxeraud, “Gadovist - gadobutrol,” Actual. Pharm., vol. 48, no. 490, pp. 47–48, 
2009. 
References   67 
 
 
[26] “Image J 1.48 - Image Processing and Analysis in Javale.” [Online]. Available: 
imagej.nih.gov/ij/download/. (accessed on July 2014) 
[27] “RadiAnt DICOM Viewer 1.9.16,” Medixant. [Online]. Available: 
http://www.radiantviewer.com/. (accessed on July 2014) 
[28] G. Helms, H. Dathe, N. Weiskopf, and P. Dechent, “Identification of signal bias in 
the variable flip angle method by linear display of the algebraic Ernst equation.,” 
Magn. Reson. Med., vol. 66, no. 3, pp. 669–77, Sep. 2011. 
[29] H. Lu, C. Clingman, X. Golay, and P. C. M. van Zijl, “Determining the longitudinal 
relaxation time (T1) of blood at 3.0 Tesla.,” Magn. Reson. Med., vol. 52, no. 3, pp. 
679–82, Sep. 2004. 
[30] R. Materne, A. M. Smith, F. Peeters, J. P. Dehoux, A. Keyeux, Y. Horsmans, and 
B. E. Van Beers, “Assessment of hepatic perfusion parameters with dynamic MRI.,” 
Magn. Reson. Med., vol. 47, no. 1, pp. 135–42, Jan. 2002. 
[31] H. P. Gavin, “The Levenberg-Marquardt method for nonlinear least squares curve-
fitting problems,” pp. 1–17, 2013. [Online]. Available: 
http://people.duke.edu/~hpgavin/ce281/lm.pdf 
.[32] K. Coenegrachts, J. Ghekiere, V. Denolin, B. Gabriele, G. Hérigault, M. 
Haspeslagh, P. Daled, S. Bipat, J. Stoker, and H. Rigauts, “Perfusion maps of the 
whole liver based on high temporal and spatial resolution contrast-enhanced MRI 
(4D THRIVE): feasibility and initial results in focal liver lesions.,” Eur. J. Radiol., vol. 
74, no. 3, pp. 529–35, Jun. 2010.  
 

